Muragaki, Y., Nitta, M., Saito, T., Tsuzuki, S., Fukui, A., Ikuta, S., . . . Kawamata, T. (2020). ACT-17 Protocol design of a matrix-type of novel clinical trial for lower-grade gliomas. Neurooncol Adv.

Muragaki, Yoshihiro, Masayuki Nitta, Taiichi Saito, Shunsuke Tsuzuki, Atsushi Fukui, Soko Ikuta, Takashi Maruyama, Takashi Komori, och Takakazu Kawamata. "ACT-17 Protocol Design of a Matrix-type of Novel Clinical Trial for Lower-grade Gliomas." Neurooncol Adv 2020.

Muragaki, Yoshihiro, et al. "ACT-17 Protocol Design of a Matrix-type of Novel Clinical Trial for Lower-grade Gliomas." Neurooncol Adv 2020.